Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07109739 · ClinicalTrials.gov registry record · NA
Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function
A NA study of Systolic Hypertension and Brachial Artery Flow-mediated Dilation, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT07109739 is a NA study of Systolic Hypertension and Brachial Artery Flow-mediated Dilation that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 144 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07109739, a NA study of Systolic Hypertension and Brachial Artery Flow-mediated Dilation, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the dose-response effects of Inspiratory Muscle Strength Training (IMST) in adults with above-normal systolic blood pressure over a 6-week period.
Conditions Studied
Interventions
- DEVICE POWERbreathe K5
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2025-10-24 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07109739
The ClinicalTrials.gov registry entry for NCT07109739 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Systolic Hypertension appearing as the primary indexed condition, and to 1 intervention - of which POWERbreathe K5 is the first listed.
NCT07109739 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07109739 about?
NCT07109739 is a clinical study titled "Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function". This study will assess the dose-response effects of Inspiratory Muscle Strength Training (IMST) in adults with above-normal systolic blood pressure over a 6-week period.
What is the current status of trial NCT07109739?
This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2025-10-24. Estimated completion is 2027-03-31.
What conditions does trial NCT07109739 study?
This clinical trial studies the following conditions: Systolic Hypertension, Brachial Artery Flow-mediated Dilation.
What interventions are being tested in trial NCT07109739?
The interventions under investigation include: POWERbreathe K5 (DEVICE).
Who is sponsoring clinical trial NCT07109739?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07109739 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systolic Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Systolic Hypertension
All registered trials for this condition
Brachial Artery Flow-mediated Dilation
All registered trials for this condition
Minnesota
All trials with a study site in Minnesota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.